Bristol-Myers Squibb Company (NYSE: BMY) is a large market cap stock with a market cap of 88.78 B. It is in the Drug Manufacturers – Major industry and sector Healthcare, with a current P/E of 18.65, a forward P/E of 17.05 and EPS of 2.88. At a stock price of 53.78 (-1.16%) it has a dividend yield of 2.90%.
EPS growth for the last five years have been 4.20%, more recently this last year it has grown by 184.60%. The next year growth is going to be about 7.10% and more long-term 9.19% after five years. EPS growth quarter over quarter is 32.40%. Sales growth for the past five years have been -1.80% and sales growth quarter over quarter is 12.30%.
For performance, Bristol-Myers Squibb Company the past week has seen a gain of -2.47%. For the last month performance for Bristol-Myers Squibb Company is 1.09%. While the last quarter is -0.20% and half year, -3.81%. Finally for the year, performance is -22.36%.
The 52-week high for Bristol-Myers Squibb Company, is at -28.80%, and for the 52-week low it comes to a value of 17.74%. The 20-day simple moving average is -1.95% and -2.08% for the 200-day simple moving average.
Volatility for the week is at 1.54%, and for the month it is 1.42%. Bristol-Myers Squibb Company, has a target price of 57.18.
In terms of debt, long term debt/equity is 0.5, and for total debt/equity Bristol-Myers Squibb Company has 0.59. The gross margin is 74.30%, while operating margin is 31.60%, the profit margin is 24.20%. The current ratio is 1.6 and the quick ratio is 1.4.
Insider ownership is at 0.20%, with instituitional ownership at 74.10%. Bristol-Myers Squibb Company has a payout ratio of 52.80%. With the total shares outstanding coming to 1650.73. The shares float is 1645.31, with the float short at 1.12%, with short ratio coming to 1.88.
In terms of returns, the return on assets see Bristol-Myers Squibb Company, get 14.50%, with its returns on investment at 20.00%. Return on equity is 31.60%. So will the investors see the target price of 57.18, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.
Bristol-Myers Squibb Company (NYSE: BMY)